Visit https://www.peervoice.com/KKY860 to view the entire programme with slides. After completing “The Impact of Earlier Diagnosis and Timelier Treatment of Primary Hyperoxaluria Type 1”, participants will be able to: Describe the pathological processes of primary hyperoxaluria type 1 (PH1) that lead to end-stage renal disease; Recognise key signs and signals in patients with PH1 and the need for early diagnosis; and Discuss current management strategies for PH1 and the emerging pharmacological therapy.